Zydus Lifesciences Stock Surges, Outperforming Nifty Pharma
By ThePip Desk
Zydus Lifesciences stock climbs for a third day, hitting Rs 1171 and significantly outperforming the Nifty Pharma index over the past year with a 19.66% gain.
Zydus Lifesciences Ltd. shares extended their upward trajectory for a third consecutive session, trading at Rs 1171 on the NSE by 12:49 IST, marking a 1.83% increase for the day.
Key Market Figures
- Current Stock Price: Rs 1171
- Daily Price Increase: 1.83%
- One-Year Stock Appreciation: 19.66%
- One-Month Stock Growth: 6.53%
- NIFTY One-Year Performance: 1.32% decline
- Nifty Pharma One-Year Performance: 22.73% decline
- Nifty Pharma One-Month Performance: 2.95% rise
- Trading Volume: 20.24 lakh shares
- Average Monthly Volume: 15.31 lakh shares
- PE Ratio (TTM, June 26): 31.42
The recent daily gain contributes to a robust long-term performance, with the stock appreciating 19.66% over the past year. This contrasts sharply with the broader market, where the NIFTY dropped 1.32% and the Nifty Pharma index declined by 22.73% during the same twelve-month period.
In the last month, Zydus Lifesciences recorded a 6.53% climb, significantly contributing to the Nifty Pharma index’s 2.95% rise. Trading activity surged, with 20.24 lakh shares exchanging hands, notably surpassing the 15.31 lakh daily average from the previous month.
The stock’s current PE ratio stands at 31.42, calculated based on its trailing twelve-month earnings ending June 26. This valuation metric provides further context to the company’s market position amidst its sustained upward momentum.